Betamethasone/Indometacin/Methocarbamol

倍他米松/吲哚美辛/美索巴莫

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBetamethasone/Indometacin/Methocarbamol
Drug Alias Name倍他米松+吲哚美辛+美索巴莫Methocarbamol+Indometacin+BetamethasoneMethocarbamol/Indometacin/Betamethasone吲哚美辛/倍他米松/美索巴莫美索巴莫/倍他米松/吲哚美辛 +[13] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionCyclooxygenases inhibitorsCarbonic anhydrase I inhibitorsGlucocorticoid receptor agonists
TargetsGlucocorticoid receptorCarbonic anhydrase ICyclooxygenases
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes MethocarbamolIndomethacinBetamethasone
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIroko
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIroko
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A